Osteosarcoma Institute
The Osteosarcoma Institute is a Dallas-based 501(c)(3) nonprofit that funds breakthrough clinical trials, translational research, and patient-support services for osteosarcoma, channeling donations into a portfolio of 10 active trials at leading global cancer centers.
- Company typePrivate
- Founded2015
- HeadquartersDallas, United States
- Headcount11–50
- GTM typeB2B and B2C
- OfferingServices
Osteosarcoma Institute firmographics
Firmographics- Name
- Osteosarcoma Institute
- Legal name
- The Osteosarcoma Institute
- Website
- https://osinst.org
- Company type
- Private
- Founded year
- 2015
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- The Osteosarcoma Institute is a Dallas-based 501(c)(3) nonprofit that funds breakthrough clinical trials, translational research, and patient-support services for osteosarcoma, channeling donations into a portfolio of 10 active trials at leading global cancer centers.
- Ownership category
- akta.pro rank
Osteosarcoma Institute industry classification
Industry- Product category
- Nonprofit Cancer Research Funding
- NAICS
- Voluntary Health Organizations (813212)
- SIC
- Services-Social Services (8300)
- akta.pro primary industry
- Health & Medical Research Grantmaking Foundations (BPAGAKAL)
Keywords
Where Osteosarcoma Institute is headquartered
LocationHeadquarters
- HQ city
- Dallas
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
Osteosarcoma Institute business model
Business model- GTM type
- B2B and B2C
- Offering type
- Services
- Cost components
- Technology or R&D, Personnel, Marketing or Sales, Operations
Revenue model
- Donations and Fundraising: The OSI operates as a 501(c)(3) nonprofit organization that raises funds through individual donations, corporate giving, foundation grants, planned giving (bequests, retirement accounts, life insurance), stock gifts, and donor-advised funds. The organization explicitly states that 100% of donations support osteosarcoma research and scientific programming.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Freemium | Monthly | Free patient support services |
Go-to-market motion1 record
Distribution channels3 records
Marketing channels8 records
Osteosarcoma Institute product offering
Product offeringCore offering
The Osteosarcoma Institute is a 501(c)(3) nonprofit foundation that funds breakthrough osteosarcoma clinical trials and scientific research through grants to academic institutions and researchers. It also provides free patient support services including OSI Connect (expert physician consultations), clinical trial matching through CareBox, and convenes scientific symposia to accelerate targeted therapy development.
Product overview
The Osteosarcoma Institute is a nonprofit research funding organization, not a traditional product company. Its offerings consist of patient support services (OSI Connect, Clinical Trial Search), research funding programs (Research Grants, Partnering for Progress), advocacy initiatives (OSI Ambassadors, Fundraising Tools), educational content (The Frontline Blog), and scientific convenings (Symposia). These services work together to fund breakthrough osteosarcoma research and support patients and families through the disease journey.
Differentiator
Problem solved
Functional benefit
Brands
- OSI Connect: Free resource connecting osteosarcoma patients and families with expert physicians to answer questions about all aspects of osteosarcoma, including treatment, possible side effects, and advice for getting the most out of visits with treating physicians.
Quantifiable outcome
- Committed $11.2 million to osteosarcoma research since inception
- +2 more outcomes
Companies that use Osteosarcoma Institute
Customer profileNamed customers1 record
Segments3 records
Ideal customer profiles3 records
Osteosarcoma Institute technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration11 records
AI capability4 records
Osteosarcoma Institute partnerships and signals
Strategic signalPartnerships
15 partnerships are on record, tiered major and strategic.
- Stand Up To CancermajorMajor cancer research foundation collaborating with OSI on osteosarcoma research initiatives. Appears as a supporting partner in OSI's clinical trial efforts.
- St. Jude Children's Research HospitalmajorLeading pediatric cancer research institution partnering with OSI on osteosarcoma research and clinical trials.
- Memorial Sloan Kettering Cancer CentermajorPremier cancer center collaborating with OSI on osteosarcoma research, including CAR T cell therapy development and genomic studies.
- MD Anderson Cancer CentermajorLeading cancer center partnering with OSI on osteosarcoma clinical trials and antibody-drug conjugate development.
- Dana-Farber Cancer InstitutemajorPremier cancer institute collaborating on OSI-funded research including circulating tumor cell studies and CAR T therapy development.
- Lurie Cancer Center (Northwestern University)majorLeading cancer research center at Northwestern University working with OSI on osteosarcoma research.
- Baylor College of MedicinemajorAcademic medical center partnering with OSI on CAR T cell and NK cell immunotherapy research for osteosarcoma.
- Weill Cornell MedicinemajorLeading medical institution collaborating on research into tumor-derived extracellular vesicles and pulmonary metastasis mechanisms.
- Vall d'Hebrón Institute of Oncology (VHIO)majorSpanish cancer research institute partnering on Phase 2 clinical trial of MYC inhibitor OMO-103 for osteosarcoma patients.
- BC Cancer Research InstitutemajorCanadian cancer research institute collaborating on G-quadruplex targeting and osteosarcoma surfaceome research.
- European Molecular Biology Laboratory (EMBL)majorEuropean research organization collaborating on chromothripsis and genomic instability studies in osteosarcoma.
- Emory University School of MedicinemajorAcademic institution working with OSI on combinatorial immunotherapy approaches for high-risk osteosarcoma.
- UCSF (University of California San Francisco)majorLeading university collaborating on STING immune response pathway activation research for osteosarcoma.
- CareBoxstrategicFree clinical trial matching service partnered with OSI to help patients find eligible clinical trials based on diagnosis, stage, symptoms, and treatment history. Shortens search process from weeks to minutes.
- AmgenmajorPharmaceutical sponsor of OSI's Complex Osteosarcoma Genome Symposium, contributing to collaborative research efforts.
Scale indicators7 records
Recent moves6 records
Expansion highlights6 records
Osteosarcoma Institute competitors and assessment
Company assessmentOthers
- QuadW Foundation (WWWW Foundation): Founding foundation that incubated the Osteosarcoma Institute after the 2015 Jackson Hole osteosarcoma expert conference. Closely related organization as OSI's creator, sharing the Tichenor family leadership and initial capital.
Direct peers
- Rally Foundation for Childhood Cancer Research: Pediatric cancer research nonprofit funding young investigators and early-stage research through community-led fundraising. Direct peer in childhood cancer grantmaking and donor-engagement model.
- Sarcoma Foundation of America: Nonprofit dedicated specifically to sarcoma research, advocacy, and patient support including osteosarcoma. Highly comparable focus on the same disease family with similar research funding and patient navigation model.
- St. Baldrick's Foundation: Volunteer-driven childhood cancer research foundation that funds research grants and clinical trials. Direct peer given overlapping pediatric cancer research funding mission and community fundraising model.
- National Pediatric Cancer Foundation: Nonprofit dedicated to funding pediatric cancer research with focus on reducing side effects and finding cures. Direct peer in pediatric cancer research funding through donations and corporate partnerships.
- CureSearch for Children's Cancer: Children's cancer research nonprofit funding clinical trials and accelerating new treatments. Direct peer given shared mission of funding pediatric oncology trials and supporting affected families.
- Alex's Lemonade Stand Foundation: Major pediatric cancer research nonprofit funding clinical trials and translational science across childhood cancers including osteosarcoma. Highly comparable donor-funded research grantmaking model serving patients, families, and researchers.
Broad incumbents
- Stand Up To Cancer: Large cancer research funding collaborative supporting translational research across cancer types; OSI already lists SU2C as a supporting partner. Broad incumbent peer overlapping in research funding and awareness-building.
- Children's Oncology Group: Largest pediatric cancer research cooperative group running the majority of US pediatric oncology clinical trials. Broad peer in pediatric cancer clinical trial infrastructure where OSI is one of many funders.
- The V Foundation for Cancer Research: Major cancer research funding nonprofit supporting all cancer types through translational research grants. Broad incumbent peer with overlapping donor-funded grantmaking model but wider cancer scope than osteosarcoma-only OSI.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
Osteosarcoma Institute social profiles
Digital presenceOsteosarcoma Institute financial estimates
Financial estimateRevenue estimate
Valuation estimate
Osteosarcoma Institute leadership team
Management profileNumber of profiles
Profiles10 records
Osteosarcoma Institute funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Osteosarcoma Institute M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Osteosarcoma Institute
What does Osteosarcoma Institute do?
The Osteosarcoma Institute is a 501(c)(3) nonprofit foundation that funds breakthrough osteosarcoma clinical trials and scientific research through grants to academic institutions and researchers. It also provides free patient support services including OSI Connect (expert physician consultations), clinical trial matching through CareBox, and convenes scientific symposia to accelerate targeted therapy development.
Is Osteosarcoma Institute a public or private company?
Osteosarcoma Institute is a private company. It is classified as nonprofit foundation owned and is currently operating.
When was Osteosarcoma Institute founded?
Osteosarcoma Institute was founded in 2015. It employs 11 to 50 people.
Where is Osteosarcoma Institute based?
Osteosarcoma Institute is headquartered in Dallas, United States, in the North America region.
How does Osteosarcoma Institute make money?
One revenue line is on record: donations and Fundraising.
Who are Osteosarcoma Institute's main competitors?
QuadW Foundation (WWWW Foundation) is listed as an others. Direct peers are Rally Foundation for Childhood Cancer Research, Sarcoma Foundation of America, St. Baldrick's Foundation, National Pediatric Cancer Foundation, CureSearch for Children's Cancer and Alex's Lemonade Stand Foundation. Broad incumbents are Stand Up To Cancer, Children's Oncology Group and The V Foundation for Cancer Research.
Does Osteosarcoma Institute have an API?
No public API is recorded for Osteosarcoma Institute.
What industry is Osteosarcoma Institute in?
Osteosarcoma Institute's product category is Nonprofit Cancer Research Funding. Its primary akta.pro industry code is BPAGAKAL, Health & Medical Research Grantmaking Foundations. Its NAICS code is 813212 and its SIC code is 8300.